Global Small Animal Imaging (in Vivo) Market worth $1.55 Billion by 2017
DALLAS, January 22, 2013 /PRNewswire/ --
The report "Global Small Animal Imaging (in Vivo) Market - By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality / Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017" analyzes the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.
Browse 117 tables and 20 figures spread through 269 pages combined with an in-depth TOC on "Global Small Animal Imaging (in Vivo) Market - By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality / Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017".
Early buyers will receive 10% customization on reports.
The global small animal imaging (in vivo) market is expected to grow at a CAGR of 14.5% from 2012 to 2017 and is classified into two types of imaging systems, namely standalone and multimodal imaging technologies. In addition, the report covers different types of imaging reagent employed in small animal research studies such as nuclear imaging reagents, optical imaging reagents, MRI contrasting reagents, CT contrast reagents and ultrasound contrast reagents. With the diverse choice of imaging technologies, parameters such as disease model, cost, ease-of-use, accessibility to imaging agents, and utility of particular imaging modality, play a crucial role in dictating researchers' choice while purchasing an imaging system.
The global small animal imaging market is valued at $789.4 million in 2012 and is expected to grow at a CAGR of 14.5% over the next five years. The small animal in vivo imaging industry has experienced numerous technological advancements, changes in market due to changes in government funding towards support for research across the globe and due to industry consolidation. It is projected that the trend of developing innovative products and enhancing existing products will continue in future to resolve the current challenges and meet the demanding needs of the market. The market shows a growing preference towards hybrid technologies such as SPECT+CT and PET + CT. This trend is expected for novel combination systems such as SPECT + MRI and PET + MRI. Technological advancements, growing adoption rate, rising application of functional imaging and an increasing number of pharma companies are the major driving factors that are enhancing the growth of the market.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals [ http://www.marketsandmarkets.com/pharmaceutical-market-research-3.html ], semiconductors and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com